MFDS — authorised 29 April 2016
- Marketing authorisation holder: ACADIA PHARMACEUTICALS INC
- Status: likely_approved
🇰🇷 Nuplazid in South Korea
MFDS authorised Nuplazid on 29 April 2016
Marketing authorisation
Nuplazid in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in South Korea
Frequently asked questions
Is Nuplazid approved in South Korea?
Yes. MFDS authorised it on 29 April 2016.
Who is the marketing authorisation holder for Nuplazid in South Korea?
ACADIA PHARMACEUTICALS INC holds the South Korean marketing authorisation.